COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

May 20, 2020

Psychopharmacology of COVID-19

Melanie BilbulCarrie L Ernst
May 31, 2020

Treatment algorithm for COVID-19: a multidisciplinary point of view

Clinical Rheumatology
Felice GalluccioMario Fajardo-Pérez
May 22, 2020
PreprintOpen Access

Convalescent plasma treatment of severe COVID-19: A matched control study

S. T. H. LiuNicole M. Bouvier
May 23, 2020
ReviewOpen Access

Management and Treatment of COVID-19: The Chinese Experience

The Canadian Journal of Cardiology
Fujun PengChristopher Chang
May 30, 2020

Emerging pharmacotherapies for COVID-19

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Rachana Salvi, Panini Patankar
May 27, 2020

Emerging pharmacotherapies for COVID-19

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Rachana Salvi, Panini Patankar
May 22, 2020

A novel coronavirus (SARS-CoV-2) and COVID-19

Casopís lékar̆ů c̆eských
Milan TrojánekFrantišek Stejskal
May 18, 2020
ReviewOpen Access

Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
J Seghatchian, F Lanza
May 15, 2020

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review

The Cochrane Database of Systematic Reviews
Sarah J ValkNicole Skoetz
May 15, 2020
ReviewOpen Access

A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?

Pulmonary Therapy
Natella MaglakelidzeTimothy J Craig

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved